Predictions
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€24.44
14.01.22
14.01.22
-
14.01.23
14.01.23
-10.19%
22.01.22
22.01.22
Risky Investment
Magenta Therapeutics
Start price
Target price
Perf. (%)
€4.08
08.01.22
08.01.22
€6.00
08.01.23
08.01.23
-26.40%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€8.16
15.01.21
15.01.21
-
15.01.22
15.01.22
-63.58%
16.01.22
16.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€123.30
17.08.21
17.08.21
-
17.08.22
17.08.22
-27.01%
12.01.22
12.01.22
Mediclin AG
Start price
Target price
Perf. (%)
€4.36
10.01.21
10.01.21
€6.00
10.01.22
10.01.22
-15.14%
11.01.22
11.01.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Novavax Inc.
Start price
Target price
Perf. (%)
€183.96
17.12.21
17.12.21
€240.00
17.12.22
17.12.22
-37.46%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Some uniques
Genocea Biosciences Inc.
Start price
Target price
Perf. (%)
€1.15
27.12.21
27.12.21
-
27.12.22
27.12.22
-18.26%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€134.44
30.12.21
30.12.21
-
30.12.22
30.12.22
-13.81%
09.01.22
09.01.22
Risky Investment
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€33.72
03.01.22
03.01.22
-
03.01.23
03.01.23
-14.00%
09.01.22
09.01.22
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.54
03.01.22
03.01.22
-
03.01.23
03.01.23
-14.69%
09.01.22
09.01.22
Risky Investment
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.88
20.12.21
20.12.21
€1.20
20.12.22
20.12.22
-25.64%
09.01.22
09.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Radius Health Inc.
Start price
Target price
Perf. (%)
€6.35
26.12.21
26.12.21
-
26.12.22
26.12.22
-7.81%
09.01.22
09.01.22
Risky Investment
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.58
21.08.21
21.08.21
€220.00
21.08.22
21.08.22
-13.54%
08.01.22
08.01.22
Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Valneva SE
Start price
Target price
Perf. (%)
€19.03
04.01.22
04.01.22
-
04.01.23
04.01.23
-7.46%
07.01.22
07.01.22
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€147.98
05.12.21
05.12.21
-
05.12.22
05.12.22
-23.17%
07.01.22
07.01.22
Could be worthwhile Investment >10% per year
Infinity Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.92
28.07.21
28.07.21
-
28.07.22
28.07.22
-25.00%
06.01.22
06.01.22
Probably not worthwhile Investment
High valuation
Organovo Holdings Inc.
Start price
Target price
Perf. (%)
€10.05
05.01.21
05.01.21
-
05.01.22
05.01.22
-68.70%
06.01.22
06.01.22
Could be worthwhile Investment >10% per year
Organovo Holdings Inc.
Start price
Target price
Perf. (%)
€10.20
01.01.21
01.01.21
€7.00
01.01.22
01.01.22
-66.98%
02.01.22
02.01.22
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
High Investments for future growth
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.26
12.12.21
12.12.21
-
12.12.22
12.12.22
9.82%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.60
12.12.21
12.12.21
-
12.12.22
12.12.22
23.60%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€3.32
12.12.21
12.12.21
-
12.12.22
12.12.22
2.65%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€151.40
12.12.21
12.12.21
-
12.12.22
12.12.22
5.67%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
12.12.21
12.12.21
-
12.12.22
12.12.22
8.73%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year